Status:
COMPLETED
A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Acute Bacterial Conjunctivitis
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.
Eligibility Criteria
Inclusion
- Clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye.
Exclusion
- Pregnant or nursing females.
- Use of any antibiotic within 72 hours of enrollment.
- Any disease conditions that could interfere with the safety and efficacy evaluations of the study drug.
- Participation in an ophthalmic drug or device research study within 30 days prior to entry into this study.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
1161 Patients enrolled
Trial Details
Trial ID
NCT00348348
Start Date
June 1 2006
End Date
July 1 2007
Last Update
March 24 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.